IP Stars

Search results

Filters

Result types
Article type
Jurisdiction
Industry sector

Showing 891 - 900 of 902 for "Pharmaceutical" with applied filters

News & Analysis

Malaysia: Merck finally shuts the door of SKB Shutters

02 October 2019 by Indran Shanmuganathan, Michelle Loi Choi Yoke, and Yap Khai Jian

Indran Shanmuganathan, Michelle Loi Choi Yoke, and Yap Khai Jian of Shearn Delamore & Co provide an in-depth analysis of the Federal Court’s decision in Merck Sharp & Dohme & Anor v Hovid Berhad, a patentee-friendly judgment which overturned a previous ruling on the assessment of dependent and independent claims

News & Analysis

A report on Patent Office disputes in Peru

27 September 2019 by Adriana Barrera

Adriana Barrera of Barrera & Asociados (BARLAW) summarizes the Peruvian Patent Office’s report on its patent and design adjudication work in the past five years

News & Analysis

Milbank welcomes four IP litigators in Los Angeles

17 August 2019 by Chris Adams and Kingsley Egbuonu

The firm hired four IP litigators, two of whom are ranked as patent stars, from a rival

News & Analysis

Mylan and Upjohn merge to form a new generics giant

30 July 2019 by Kingsley Egbuonu

Four law firms were involved in the multi-billion dollar merger of Mylan and Upjohn, Pfizer’s off-patent branded and generics business
News & Analysis

IP people moves and firm news: Asia-Pacific and Europe

01 July 2019 by Kingsley Egbuonu

Some IP firms in Asia-Pacific and Europe announced promotions and appointments today
News & Analysis

The key regulatory matters affected by Brexit

05 June 2019 by Alexander Robinson and Stephen Garner

Alexander Robinson and Stephen Garner of Mathys & Squire explore some of the regulatory issues in the life sciences and pharmaceutical sectors that are likely to be affected by Brexit
News & Analysis

Proposed BPCIA reforms: More music, same dance

16 May 2019 by Paul A Ainsworth and Lauren A Watt

Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.
News & Analysis

Windels Marx takes Budd Larner's IP team

17 April 2019 by Kingsley Egbuonu

The firm strengthened its IP practice in New Jersey by hiring Andrew J Miller and his IP team
News & Analysis

Court decides on cases concerning a claim term mistake and utility

31 August 2018 by Managing Intellectual Property

The decision of the Full Federal Court in GlaxoSmithKline (GSK) Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited (2018) FCAFC 71 (May 10 2018) indicates that a mistake in a claim cannot be ignored even where the skilled person understands that a mistake has been made.
News & Analysis

AG provides an advisory opinion on Article 3(a) of the SPC Regulation

02 July 2018 by Sybille Pfender

At the end of April 2018, Advocate General (AG) Wathelet handed down an advisory opinion regarding the first of three recent referrals to the CJEU (C-121/17). This concerns the interpretation of Article 3(a) of Regulation (EC) No 469/2009.
Load more